Search Results - "Ahn, Nayeon"
-
1
Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes
Published in Scientific reports (04-07-2019)“…The present study evaluated the ability of the visceral adiposity index (VAI), the lipid accumulation product (LAP), and product of triglycerides and glucose…”
Get full text
Journal Article -
2
Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018
Published in European journal of clinical pharmacology (01-04-2022)“…Purpose The German annual drug prescription-report has indicated overuse of proton pump inhibitors (PPIs) for many years; however, little was known about the…”
Get full text
Journal Article -
3
Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study
Published in European journal of clinical pharmacology (01-07-2021)“…Purpose Due to conflicting scientific evidence for an increased risk of dementia by intake of proton pump inhibitors (PPIs), this study investigates…”
Get full text
Journal Article -
4
Do proton pump inhibitors increase the risk of dementia? A systematic review, meta‐analysis and bias analysis
Published in British journal of clinical pharmacology (01-02-2023)“…Aim Previous studies on the association between proton pump inhibitor (PPI) intake and the increased risk of dementia has shown discrepancies in their…”
Get full text
Journal Article -
5
Emulating a target trial of proton pump inhibitors and dementia risk using claims data
Published in European journal of neurology (01-05-2022)“…Background and purpose Understanding the adverse effects of proton pump inhibitors (PPIs) is important due to their widespread use, but the available evidence…”
Get full text
Journal Article -
6
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany
Published in Drugs & aging (01-07-2023)“…Background Cumulative evidence of dementia risk in patients taking proton pump inhibitors (PPIs) is still inconclusive, probably due to a variety of study…”
Get full text
Journal Article -
7
The long‐term risk for myocardial infarction or stroke after proton pump inhibitor therapy (2008‐2018)
Published in Alimentary pharmacology & therapeutics (01-10-2021)“…Summary Background Proton pump inhibitors (PPIs) are well tolerated in the short term but have recently been associated with increased long‐term cardiovascular…”
Get full text
Journal Article -
8
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: A cross‐sectional study
Published in Pharmacotherapy (01-02-2021)“…Study Objective Long‐term intake of proton pump inhibitors (PPIs) might increase the risk of cardiovascular events. One suggested mechanism is that PPIs…”
Get full text
Journal Article -
9
Letter: proton pump inhibitors and risk of myocardial infarction—authors' reply
Published in Alimentary pharmacology & therapeutics (01-01-2022)“…LINKED CONTENT This article is linked to Nolde et al papers. To view these articles, visit https://doi.org/10.1111/apt.16565 and…”
Get full text
Journal Article -
10
Proton pump inhibitors and the risk of cardiovascular events and cardiovascular mortality: A systematic review and meta-analysis of observational studies
Published in European journal of internal medicine (01-12-2022)“…BACKGROUND AND AIMSObservational research has indicated that proton pump inhibitors (PPIs) might increase the long-term risk of cardiovascular events. This…”
Get full text
Journal Article -
11
Impact of Targeted Interventions on Trends in Central Line-Associated Bloodstream Infection: A Single-Center Experience From the Republic of Korea
Published in Critical care medicine (01-06-2017)“…OBJECTIVE:To assess the impact of targeted interventions on trends in central line-associated bloodstream infection. DESIGN:A before-and-after study between…”
Get full text
Journal Article